chrisvoncsefalvay/vaers-outcomes huggingface dataset:
extreme abdominal pain; nausea; vomiting; migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), ABDOMINAL PAIN (extreme abdominal pain), NAUSEA (nausea) and VOMITING (vomiting) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced MIGRAINE (migraine), NAUSEA (nausea) and VOMITING (vomiting). On 25-Jun-2021, the patient experienced ABDOMINAL PAIN (extreme abdominal pain). The patient was treated with ACETAMINOPHEN ongoing from 23-Jun-2021 at an unspecified dose and frequency and INVERT SUGAR, PHOSPHORIC ACID (EMETROL FISONS) ongoing from 23-Jun-2021 at an unspecified dose and frequency. At the time of the report, MIGRAINE (migraine), ABDOMINAL PAIN (extreme abdominal pain), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme increased: extremely high (High) Her liver enzymes are extremely high on the results of her blood tests..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No concomitant medication was mentioned.
Pt recvd 1 dose of Hep B vax on 7FEB90 & 2 doses of Engerix-B on 22MAR90 & 13AUG90; NOV90 Hep B surface antibody was neg; pt recvd 3 booster doses of Engerix on 3DEC90; 7JAN91 & 29MAY91 SEP 91 HBSAB pos;
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN  11/30/2021 -- RECURRENCE OF SAME SYMPTOMS
27 y/o AD WF CAPT presented to health center with left eyelid twitching up to 15x daily since 08/10/08 and intermittent daily frontal HA's, which began about 3 hours after receipt of AVA #1 and Typhoid IM vaccines on 08/08/08 in preparation for deployment on 9/01/08.  Symptoms: Fasciculation, Headache, general.
Shortness of breath, shaky, headache, dizzy, weakness.  Started about 45 mins after vaccine.  Felt bad for about 2 days with weakness and light headed feeling.  The worse was day of vaccine.
fever Tmax 104.9 R w/in 24 hrs of vax; mgmt: motrin 100/5 & tepid bath- 3/4tsp 98 pm fever >102.5
A report has been received from a Pharmacist concerning a 71 year old, male subject, who had been receiving FLUMIST. FLUMIST started on 09-Nov-2013. PharmD stated: another Pharmacist gave QUAD to a 71 year old male. The patient experienced  FLUMIST given to 71 year old male which started on 09-Nov-2013. The outcome of the event of FLUMIST given to 71 year old male is unknown. The report was considered to be non-serious by the reporter.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 23-OCT-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) dose, route and anatomical location were not provided. There was no concomitant medication provided. On unknown dates, the PNEUMOVAX had temperature excursions for 72 hours with lowest recorded temperature of 28F (-2.2 Celsius) and 40 hours with the highest recorded temperature 47 F (8.3 Celsius). The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
ADULT OBSTRUCTIVE SLEEP APNEA, MILD HYPOTENSION 12/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Myalgia, Fever,  Sore throat, arm soreness Narrative: Symptoms reported 12/24 and Per Dr. visit report this employee felt well enough to work the next day.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date, the patient was vaccinated with RECOMBIVAX that went through an unsupported temperature excursion from 29-OCT-2013 to 06-NOV-2013 (dose, route and lot number were not provided). No concomitant medications were reported. No adverse effect reported. This is one of several reports received from the same source (MARRS# 1311USA003162, MARRS# 1311USA004586 and MARRS# 1311USA004587). Additional information has been requested.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) one of the detainees was taken to the hospital and tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.  No treatment information reported.   This case was linked to MOD-2021-163872 (E2B Linked Report).; Sender's Comments:  MOD-2021-163872:Same reporter
Information has been received from a pharmacist concerning a 77 year old female who on 22-JUL-2007 was vaccinated with a dose of ZOSTAVAX. On approximately 28-JUL-2007 the patient developed an erythematous rash and swelling around the injection site the size of a pancake. No further information was provided. No further information is available.
Pain in eyes, head, nausea, fatigue and hematoma on left eyelid.
Rash that started two days after vaccine was administered and is still present 9/8/03
arm pain on the injection site and arm pit. enlarge lymph node, headache, fatigue, low grade fever, chill. These took about 10 days I took Tylenol and sleep a lot
Patient reported hot, tingly, and itchy face immediately after vaccine. Face was flushed and felt like heart rate more rapid than normal and some chest tightness. Patient denied any itching or tingling in throat or mouth and also thought it might just be her anxiety. After a few minutes patient reported symptoms not worse or spreading but about the same. Had patient take off mask to breathe better, have some juice and gave 50mg oral liquid benadryl. Patient was feeling better about 3 minutes later and stayed for additional 15 minutes for observation and then left on her own with her son. Son would drive home.
Patient began complaining of dizziness and changes in vision (but no loss of consciousness) following 1st dose of COVID-19 vaccine. Patient was also diaphoretic and hypotensive with blood pressures of 82/57, 80/36 mmHg. No wheezing or respiratory distress were noted, and the patient did not endorse any changes in sensation/tingling/itching to face, lip or mouth.  Patient was taken to the ED for monitoring. Workup in the ED was negative, and the patient was discharged home.
Patient who is complaining of sore arm; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   The reporter considered the pain in arm to be possibly related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced sore arm that she relates back to her second Shingrix vaccination. The patient denies any nodule or visible abnormality. The reporter asked if was this a known issue and any advice would be appreciated. The consent to follow-up was granted.
This spontaneous report was received from a physician via company representative and refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates in past, the patients were vaccinated with RECOMBIVAX HB (dosing details were not reported) for prophylaxis. Physician reported that all the patients had negative antibodies (Hepatitis B surface antibody negative) and were needed to be revaccinated. Outcome of the event was unknown. Causality assessment was not provided. Additional information is not expected, no contact details were provided.
My daughter is polluted with full blown chicken pox diagnosed by her pediatrician as being the result of the vaccination.
Day of vaccination- cloudy, disoriented Next day- prolonged extreme soreness at injection site
Information has been received from a registered nurse concerning unspecified number of patients of unknown gender and their age range was from 1 year to 18 years old. The patients' relevant medical history was not reported. On unknown dates, the patients were vaccinated with M-M-R II (lot# K000174, expiration date 08-JAN-2015) (dose, dose number and route not reported) which were improperly stored. Information about concomitant medication was not reported. The temperature excursion for M-M-R II was not supported with in-house stability data. It was reported that there had been two episodes of temperature excursion, after the second excursion, doses of improperly stored vaccines were administered to patients. The registered nurse provided that there had been no adverse events reported following the administration of the vaccinations and on need for revaccination. PQC (product quality complaint) was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
WORSENING delirium in addition to her memory loss since being admitted to Hospital (APRIL 2021 and May 2021). Workup at the hospital was negative for infectious process, dehydration or stroke. She was discharged to geriatric psych facility for 1 week, with no improvement in symptoms. Family has seen symptoms of delirium prior to hospitalization, such as hallucinations and paranoia. Since these hospitalizations patient is experiencing further paranoia, refusing to eat or take medications provided by her sons, as she thinks they are "trying to poison me".  Her first hospitalization was within 24hrs of first injection, the second hospitalization was within 24hrs of her second injection
feeling horrible; getting sicker; This case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In June 2022, unknown after receiving Shingles vaccine, the patient experienced feels awful and sickness. On an unknown date, the outcome of the feels awful and sickness were not recovered/not resolved.   It was unknown if the reporter considered the feels awful and sickness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 28-JUN-2022 Reporter's Comment: This case was reported by a consumer via interactive digital media. The patient self-reported this case. The patient was feeling horrible and getting sicker the last 2 days.
Confusion with time of day by about 24 hours; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO182) via an unspecified route of administration in the left arm on 05May2021 at 08:15 as a single dose for COVID-19 immunisation. Medical history included blood pressure. The patient had unspecified allergies. Concomitant medications included Blood Pressure (BP) medications (MANUFACTURER UNKNOWN) and herbal teas (MANUFACTURER UNKNOWN), both taken from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 09:45, the patient experienced confusion with time of day by about 24 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event confusion was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Rash on Bilat legs, knees, up thighs, knot on R thigh. Rash on stomach blotchy warm to touch. Prescribed Prednisolone 15/5 1.5 tsp po daily x 3 d, cephalexin 250/5 7 mL po BID x 10 d, hydrocortisone oint 2.5% apply topically BID x 10 d. RTC PRN.
pt recvd vax & started not feeling well on sat 15oct; sl fever & lasted till tues 18oct; went to MD; pt took apap; c/o of eye infect; feels weak; tx w/ atb;
pt recv vax; lt arm swollen, red at site, painful to lt above shoulder level;HA, rash & n&v;pain in lt VE & sensation of numbness from shoulder down;arm red/swollen;saw MD who gave migraine meds;
Severe headache; Fever; Chills; Soreness at injection site; Malaise; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 at an unspecified date. Patient took Advil for symptoms after receiving the second dose of the COVID-19 vaccine and reported the Advil helped to reduce discomfort. Patient takes low dose oral contraceptives but reports taking no other medications. The patient experienced severe headache, fever, chills, soreness at injection site and malaise on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
This spontaneous report as received from a medical assistant (M.A.) refers to an unspecified number of patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) lot # L024252 with expiration date 30-JUN-2017 and lot# reported as L026406 with expiration date 12-NOV-2015 (which was expired at the time of the report, however it was not expired when administered) (dose and route of administration were not provided). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information is not expected as no consent to contact Health Care Professional was given.
Report side effects; Breathing problem; Asthma problems; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Report side effects), DYSPNEA (Breathing problem), ASTHMA (Asthma problems) and ASTHENIA (Weakness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A, 010M20A and 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease, Hypothyroidism and Asthma. Concomitant products included VITAMIN D3, THYROID (ARMOUR THYROID), SERTRALINE, ATOMOXETINE and OMEPRAZOLE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced DYSPNEA (Breathing problem), ASTHMA (Asthma problems) and ASTHENIA (Weakness). On an unknown date, the patient experienced VACCINATION COMPLICATION (Report side effects). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Report side effects) outcome was unknown and DYSPNEA (Breathing problem), ASTHMA (Asthma problems) and ASTHENIA (Weakness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (normal) normal. On an unknown date, Oxygen saturation: 97-98 (normal) normal.         Treatment medication include butanol Inhaler.   This case was linked to MOD-2021-313599 (Parent-Child Link). This case was linked to MOD-2021-313591 (Patient Link).   See case MOD-2021-313599 for details regarding the child case.  Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up received on 08-sep-2021 and contains no new information On 08-Sep-2021: Follow up received on 08-SEP-2021 Reporter information updated, patient demographics updated, medical history updated, lab data updated, concomitant medication updated, treatment medication updated, events updated.
Chronic hives began 12-18 hours after first injection. They have not stopped since. She takes 2 doses of Pepcid and Zyrtec daily. She also uses hydrocortisone cream PRN. Ped and allergist both agree it is a direct result to the vaccine. If she misses a single dose, hives are back within an hour. She never had an allergic reaction or hives prior to this.
Information has been received from a consumer concerning her 18 month old son who was vaccinated with a third dose of COMVAX. Subsequently the patient experienced an injection site reaction. The patient had redness at the injection site. At the time of the report the patient's outcome was unknown. No further information is available.
High fever, chills, headache frontal lobe, nauseated, severe upper teeth pain -severe numbness in my upper teeth same teeth and same area, which then became swollen bleeding gums .  This is still continuing. Extremely fatigued. All symptoms have gone EXCEPT teeth upper palate area. Dr. Said to report this and My Dentist said to report this. Their medical expertise this is related to the Injection.
Patient had right side face swelling, from eye to top of lip. Stated shortness of breath.
Headache, Fever, started with headache and tireness, by 8pm extreme fatigue, by 1am he had fever and body aches  Narrative:
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 57-year-old female patient who received HAVRIX (batch number 3C7ZG, expiry date 29th January 2021) for prophylaxis. On 30th November 2018, the patient received the 2nd dose of HAVRIX. On 30th November 2018, immediately after receiving HAVRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to HAVRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter reported that, the patient experienced pain during administration of HAVRIX. Pain spreads down the hand and then subsided. The patient did not experience same symptoms during the 1st dose. The reporter gave consent to follow up. This case was 1 of the 3 linked cases, reported by same reporter.
REDNESS, SWELLING, SEVERE ITCHING OF LEFT SHOULDER-JAW AND HAIR LINE, SHORTNESS OF BREATH. SUNDAY 2 08:30PM RASH ON NECK AND CHEST.
Patient was diagnosed with hypertension about 4-5 months after the vaccine, but had not had blood pressure checked between the vaccination and the diagnosis of hypertension.  It was done at a dental visit.  She was found to have a high aldosterone to renin ration, but blood pressures were treated easily with amlodipine.
Maculopapular rash to face, scalp, neck and trunk that started 3 days after vaccine (1/9/16). Preceeded by 2 days fever 102 that resolved 24 hr before rash appeared.
Have pain to site and worsening to the point where I have to use my right arm to move my left one.  Not moving it much since 1/15/21
This is an instance of breakthrough COVID-19 after which death occurred.   The individual was vaccinated with the Pfizer product on 08/13/2021 and 09/03/2021. They presented to Emergency Department on 01/18/2022 after 7 days of malaise, fatigue, reduced appetite. They were admitted to hospital on 01/18/2022. COVID-19 test on 01/18/2022 was negative. The individual experienced complications of pneumonia, kidney injury, respiratory distress, Strep pneumo infection, Legionella infection, and that pre-existing lung cancer had advanced and possible spread to kidneys. The individual refused any additional chemoradiation for the cancer. An additional COVID-19 test on 01/26/2022 was positive. They were discharged to an unspecified correctional facility on 02/06/2022 to continue palliative care. The individual died on  02/13/2022.
Information has been received from a physician concerning an unspecified number of patients (at least 5) who on unspecified dates were vaccinated with doses of Varivax. Subsequently the patients developed breakthrough cases of chickenpox. The patients' outcomes were not reported. No further information is available.
Rash/itching around the injection site that has persisted for two weeks so far.  Mild Body/shoulder aches which have persisted for two weeks so far.  Occasional feelings of fatigue (perhaps once every day) which have peristed for two weeks so far.